Schedule 13D ownership disclosure

OUTLOOK THERAPEUTICS INC

Common Stock, par value $0.01 per share · CUSIP: 69012T305

Event date: 2025-01-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • GMS VENTURES & INVESTMENTSReported CIK 0001804598

    Shares: 12,725,216.00 · Class: 38.6%

  • SUKHTIAN GHIATH M.Reported CIK 0001717441

    Shares: 12,725,216.00 · Class: 38.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-25-000063
Form type
SCHEDULE 13D/A
Filer
GMS Ventures & Investments
CIK
CIK 1804598
Filed
Jan 22, 2025
Reporting period
Jan 17, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub